95 related articles for article (PubMed ID: 21806491)
1. Platelet activation in chronic cocaine users: effect of short term abstinence.
Pereira J; Sáez CG; Pallavicini J; Panes O; Pereira-Flores K; Cabreras MJ; Massardo T; Mezzano D
Platelets; 2011; 22(8):596-601. PubMed ID: 21806491
[TBL] [Abstract][Full Text] [Related]
2. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users.
Sáez CG; Olivares P; Pallavicini J; Panes O; Moreno N; Massardo T; Mezzano D; Pereira J
Thromb Res; 2011 Oct; 128(4):e18-23. PubMed ID: 21601240
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
Kälsch T; Elmas E; Nguyen XD; Suvajac N; Klüter H; Borggrefe M; Dempfle CE
Basic Res Cardiol; 2007 Sep; 102(5):460-6. PubMed ID: 17624488
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
6. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
7. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea.
Akinnusi ME; Paasch LL; Szarpa KR; Wallace PK; El Solh AA
Respiration; 2009; 77(1):25-31. PubMed ID: 18812691
[TBL] [Abstract][Full Text] [Related]
8. Elevated platelet-monocyte complexes in patients with psoriatic arthritis.
Pamuk GE; Nuri Pamuk O; Orüm H; Arican O; Turgut B; Demir M
Platelets; 2009 Nov; 20(7):493-7. PubMed ID: 19852688
[TBL] [Abstract][Full Text] [Related]
9. Changes in regional cerebral blood flow are associated with endothelial dysfunction markers in cocaine-dependent patients under recent abstinence.
Massardo T; Quintana JC; Jaimovich R; Sáez CG; Cabreras MJ; Pereira-Flores K; Ibáñez C; Pallavicini J; Véliz J; Mezzano D; Pereira J
J Addict Med; 2015; 9(2):139-46. PubMed ID: 25700140
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
11. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
12. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Schins A; Hamulyák K; Scharpé S; Lousberg R; Van Melle J; Crijns H; Honig A
Life Sci; 2004 Dec; 76(6):637-50. PubMed ID: 15567189
[TBL] [Abstract][Full Text] [Related]
13. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk.
Ahn ER; Lander G; Jy W; Bidot CJ; Jimenez JJ; Horstman LL; Ahn YS
Thromb Res; 2004; 114(2):143-8. PubMed ID: 15306157
[TBL] [Abstract][Full Text] [Related]
14. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers.
Burdess A; Michelsen AE; Brosstad F; Fox KA; Newby DE; Nimmo AF
Thromb Res; 2012 Jan; 129(1):50-5. PubMed ID: 21937092
[TBL] [Abstract][Full Text] [Related]
16. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
17. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.
Nomura S; Inami N; Kanazawa S; Iwasaka T; Fukuhara S
Stem Cells; 2004; 22(5):696-703. PubMed ID: 15342934
[TBL] [Abstract][Full Text] [Related]
18. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients.
Lukasik M; Dworacki G; Michalak S; Kufel-Grabowska J; Golanski J; Watala C; Kozubski W
Thromb Res; 2011 Nov; 128(5):e73-80. PubMed ID: 21788065
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
